NEW YORK (Reuters Health) – For patients who require stroke prevention therapy and who also undergo coronary stenting, combining oral anticoagulation with aspirin and clopidogrel provides better antithrombotic…
NEW YORK (Reuters Health) – Compared to the standard 75-mg/d maintenance dose of clopidogrel, 150 mg/d produces greater platelet inhibition, higher flow-mediated vasodilation, and reduced inflammation – all…
NEW YORK (Reuters Health) – For mild persistent asthma, fluticasone propionate with salmeterol cuts the risk of exacerbations more than ciclesonide, but both regimens effectively control daily symptoms.…
NEW YORK (Reuters Health) – In patients with stage 1 and 2 hypertension, the experimental angiotensin receptor blocker (ARB) azilsartan medoxomil lowers blood pressure better than maximal doses…
NEW YORK (Reuters Health) – An analysis of “real-life” data from a French myocardial infarction (MI) registry fails to show any clinically relevant interaction between clopidogrel and proton…
NEW YORK (Reuters Health) – Suppressive therapy with corticosteroids and antihistamines is effective for managing clopidogrel hypersensitivity in the majority of cases, allowing antiplatelet therapy to continue uninterrupted,…
NEW YORK (Reuters Health) – Among patients with myeloma treated with thalidomide, antithrombotic prophylactic therapies with aspirin, warfarin or enoxaparin reduce thromboembolic events to a similar degree, according…
NEW YORK (Reuters Health) – Insulin degludec, an ultra-long-acting basal insulin, provides glycemic control in type 1 diabetes similar to that of insulin glargine but with lower occurrence…
NEW YORK (Reuters Health) – The combination of fibrate and statin therapy is a safe and efficacious treatment option for women with multiple lipid abnormalities, a multicenter team…
NEW YORK (Reuters Health) – The selective sinoatrial I-f current inhibitor ivabradine lowers heart rate in patients with stable coronary artery disease and impaired left ventricular systolic function…